Neogenomics (NEO) PT Lowered to $26 and Could Recovery in the Second Half, Here's Why - Craig-Hallum
Tweet Send to a Friend
Craig-Hallum analyst Alex Nowak lowered the price target on Neogenomics (NASDAQ: NEO) to $26.00 (from $30.00) after the company announced ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
